5AM VENTURES
5AM Ventures is a venture capital firm that offers seed- and early-stage investments to its clients. The company’s client portfolio consists of firms in the biopharmaceutical, life sciences, medical technology, and research instrument industries. 5AM Ventures was founded in 2002 by John Diekman and Andrew Schwab and is based in California.
5AM VENTURES
Industry:
Biotechnology Finance Life Science Venture Capital
Founded:
2002-01-01
Status:
Active
Contact:
415-993-8570
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default LetsEncrypt Apple Mobile Web Clips Icon WordPress Content Delivery Network Wordpress Plugins Microsoft Exchange Online
Similar Organizations
BioAdvance
BioAdvance is a Pennsylvania-based venture capital firm that provides funding to life sciences startups.
Converge
Converge is a venture capital firm that specializes in seed, startup, early Series A, and early-stage investments.
Detroit Venture Partners
Detroit Venture Partners is an American venture capital firm that funds seed- and early-stage technology companies.
Motley Fool Ventures
Motley Fool Ventures is a venture capital that primarily invests in tech-enabled companies.
TriplePoint Ventures
TriplePoint Ventures is a venture capital firm that finances seed and early stage investments of life sciences and technology sectors.
VentureFriends
VentureFriends is a venture capital fund that invests in tech-enabled companies.
Current Employees Featured
Founder
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2022-08-10 | Disc Medicine | 5AM Ventures investment in Venture Round - Disc Medicine | N/A |
| 2022-07-20 | CAMP4 Therapeutics | 5AM Ventures investment in Series B - CAMP4 Therapeutics | 100 M USD |
| 2022-06-23 | Magnetic Insight | 5AM Ventures investment in Series B - Magnetic Insight | 17 M USD |
| 2022-04-19 | Dianthus Therapeutics | 5AM Ventures investment in Series A - Dianthus Therapeutics | 100 M USD |
| 2021-12-03 | Pear Therapeutics | 5AM Ventures investment in Post-IPO Equity - Pear Therapeutics | 125 M USD |
| 2021-11-05 | GlycoEra | 5AM Ventures investment in Series A - GlycoEra | 45 M CHF |
| 2021-10-18 | Radionetics Oncology | 5AM Ventures investment in Private Equity Round - Radionetics Oncology | 30 M USD |
| 2021-10-12 | CinCor Pharma | 5AM Ventures investment in Series B - CinCor Pharma | 143 M USD |
| 2021-09-29 | Expansion Therapeutics | 5AM Ventures investment in Series B - Expansion Therapeutics | 80 M USD |
| 2021-09-09 | RareCyte | 5AM Ventures investment in Series G - RareCyte | 24 M USD |